Table 4.
Clinicopathological characteristics | Univariate | analysis | |
---|---|---|---|
Odds ratio | 95%CI | P value | |
Age(years): | |||
≤50, n=24 | 1 | ||
>50, n=35 | 1.1 | 0.4-3.3 | 0.86 |
FIGO stage: | |||
IIIC, n=47 | 1 | ||
IV, n=12 | 1.1 | 0.3-4.2 | 0.92 |
Ascites (ml): | |||
≤1000, n=20 | 1 | ||
>1000, n=33 | 0.5 | 0.1-1.7 | 0.19 |
CA125 level before NACT (IU/ml) | |||
<500, n=27 | 1 | ||
≥ 500, n=30 | 0.7 | 0.2-2.0 | 0.50 |
HE4 level before NACT (pmol) | |||
<500, n=29 | 1 | ||
≥500, n=30 | 0.5 | 0.2-1.7 | 0.16 |
Level of proteins of IGF-system in ascites before NACT (ng/mg of protein) | |||
IGF-I | |||
≥2.48, n=26 | 1 | ||
<2.48, n=27 | 3.7 | 1.0-6.7 | 0.048 |
IGF-II | |||
<115, n=26 | 1 | ||
≥115, n=27 | 1.6 | 0.4-4.8 | 0.48 |
IGFBP-3 | |||
<190, n=26 | 1 | ||
≥190, n=27 | 1.9 | 0.5-5.0 | 0.32 |
IGFBP-4 | |||
<97.0, n=27 | 1 | ||
≥97.0, n=26 | 0.9 | 0.4-2.4 | 0.57 |
PAPP-A | |||
Absent, n=23 | 1 | ||
Present, n=30 | 0.6 | 0.3-1.9 | 0.44 |